CYRAMZA

CYRAMZA

Manufacturer:

Eli Lilly
Basic Prescribing Info
Contents
ramucirumab.
CIMS Class
Targeted Cancer Therapy
ATC Classification
L01FG02 - ramucirumab ; Belongs to the class of VEGF/VEGFR (Vascular Endothelial Growth Factor) inhibitors. Used in the treatment of cancer.
Presentation/Packing
Form
CYRAMZA inj
Packing/Price
100 mg x 10ml (51,546 INR);500 mg x 50ml (257,532 INR)
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in